Premium Nahrungsergänzungsmittel | artgerecht

Thymosin Beta-4 Fragment – Effects & Applications

The thymosin beta-4 fragment is a bioactive peptide derived from the full-length thymosin beta-4 protein, exhibiting regenerative, anti-inflammatory, and tissue-repairing properties.

Regular tips about health Regular tips about health

Things worth knowing about "Thymosin Beta-4 Fragment"

The thymosin beta-4 fragment is a bioactive peptide derived from the full-length thymosin beta-4 protein, exhibiting regenerative, anti-inflammatory, and tissue-repairing properties.

What Is the Thymosin Beta-4 Fragment?

The thymosin beta-4 fragment refers to short peptide sequences derived from the full-length thymosin beta-4 protein (Tβ4). Thymosin beta-4 is a naturally occurring 43-amino acid polypeptide found in virtually all human cells, playing a central role in cell migration, wound healing, and tissue repair. Through proteolytic cleavage, smaller fragments are generated that can exert independent biological activities. The most well-known of these fragments is Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline), representing the first four amino acids of the thymosin beta-4 protein.

Mechanism of Action

Thymosin beta-4 fragments act through several molecular mechanisms:

Actin sequestration: Full-length Tβ4 and its fragments bind G-actin, thereby regulating actin cytoskeleton polymerization and influencing cell motility.
Anti-inflammatory effects: The fragment Ac-SDKP inhibits hematopoietic stem cell proliferation and reduces the release of pro-inflammatory cytokines such as TNF-alpha and IL-1beta.
Angiogenesis: Thymosin beta-4 fragments promote the formation of new blood vessels by stimulating the migration and proliferation of endothelial cells.
Antifibrotic action: Ac-SDKP in particular exerts antifibrotic effects by inhibiting the differentiation of fibroblasts into myofibroblasts and reducing excessive collagen production.
Neuroprotective effects: Preclinical studies have demonstrated neuroprotective and neuroregenerative properties, suggesting support for neuronal survival.

Medical Applications

Research into thymosin beta-4 fragments spans several clinical and preclinical areas of interest:

Wound Healing and Tissue Repair

Thymosin beta-4 fragments accelerate wound healing by promoting the migration of keratinocytes and fibroblasts to the wound site. Clinical studies have shown improved healing of chronic wounds and corneal injuries.

Cardiac Regeneration

Preclinical and early clinical studies have demonstrated that thymosin beta-4 and its fragments can stimulate the regeneration of cardiomyocytes following myocardial infarction and improve cardiac function.

Neuroprotective Applications

Animal models have been used to investigate whether thymosin beta-4 fragments can exert protective and regenerative effects on the nervous system following stroke or traumatic brain injury.

Antifibrotic Therapy

The fragment Ac-SDKP is being investigated as a potential therapeutic agent against organ fibrosis, particularly cardiac and renal fibrosis, due to its ability to inhibit excessive scar tissue formation.

Current State of Clinical Research

While thymosin beta-4 itself has been evaluated in Phase II clinical trials in patients with ocular surface injuries and venous leg ulcers, many specific fragments remain in preclinical or early clinical development stages. The peptide Ac-SDKP is released from thymosin beta-4 by the enzyme prolyl oligopeptidase and is detectable in blood plasma. ACE inhibitors (angiotensin-converting enzyme inhibitors) raise plasma Ac-SDKP levels, which may contribute to the cardioprotective effects associated with this drug class.

Safety and Side Effects

In clinical studies conducted to date, thymosin beta-4 has been well tolerated, with rare and generally mild adverse effects. The safety profile of isolated fragments has not yet been fully established. Use should therefore be limited to clinical trial settings or be conducted under strict medical supervision. Individuals with autoimmune conditions or active malignancies should exercise particular caution, as the effects on immune regulation are not yet fully understood.

References

Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine, 2005;11(9):421-429.
Philp D, Kleinman HK. Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide. Annals of the New York Academy of Sciences, 2010;1194:81-86.
Peng H, et al. Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction. Kidney International, 2003;63(3):955-963.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.